Skip to main content

Table 1 Baseline data of all HCC patients

From: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma

Characteristic Type n Proportion (%)
Age  <  = 65 235 62.33
 > 65 141 37.40
unknow 1 0.27
Gender FEMALE 122 32.36
MALE 255 67.64
Grade G1–2 235 62.33
G3–4 137 36.34
unknow 5 1.33
Stage Stage I–II 262 69.50
Stage III–IV 91 24.14
unknow 24 6.37
T stage T1–2 280 74.27
T3–4 94 24.93
unknow 3 0.80
M stage M0 272 72.15
M1 4 1.06
unknow 101 26.79
N stage N0 257 68.17
N1 4 1.06
unknow 116 30.77